BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Friday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Down 16.8 %

NASDAQ BIOL opened at $0.01 on Friday. The stock’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. BIOLASE has a twelve month low of $0.02 and a twelve month high of $1.94. The company has a market capitalization of $416,919.36, a price-to-earnings ratio of 0.00 and a beta of 0.67.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.